Skip to main content
. 2022 Mar 29;98(3):222–227. doi: 10.1136/sextrans-2021-055352

Table 1.

Summary of study characteristics of included studies

First author, publication year, reference number Study design Timing of specimen collection Specimen type Total enrolled, N Sample size for outcome,
events in women with Mycoplasma genitalium/total with the outcome, n/n (%)
PTB PROM LBW SAB PND
Agger, 201421 Cohort 1st or 2nd trimester Endocervical swab 783 676,
0/54 (0)
NR NR NR NR
Averbach, 201319 Cohort* 1st or 2nd trimester Endocervical swab 100 66,
1/11 (9)
NR 81,
1/11 (9)
81,
1/9 (11)
NR
Choi, 201222 Case–control NR Vaginal swab 217 217,
0/100 (0)
NR NR NR NR
Edwards, 200623 Cohort NR Not clear 137 134† NR NR NR NR
Hitti, 20103 Case–control* <48 hours post partum Endocervical swab 1338 1328,
29/661 (4)
NR NR NR NR
Kataoka, 200624 Cohort 1st trimester Vaginal swab 1040 871,
0/15 (0)
871,
0/7 (0)
NR 877,
0/5 (0)
872,
0/1 (0)
Labbe, 200220 Case–control <24 hours post partum Endocervical swab 1014 799,
16/119 (13)
NR NR 653,
2/53 (4)
725,
8/125 (6)
Oakeshott, 200425 Cohort 1st trimester Urine 1216 699,
0/39 (0)
NR NR 894,
1/92 (1)
NR
Rahimkhani, 201827 Cohort 1st or 2nd trimester Urine 119 NR NR NR 119,
6/31 (19)
NR
Short, 201026 Case–control* NR Urine 216 NR NR NR 213,
3/82 (4)
NR

*Authors reported both univariable and multivariable analyses.

†Numerator and denominator not reported in text. OR and 95% CI, as reported by authors, used in meta-analysis.

LBW, low birth weight; NR, not reported; PROM, premature rupture of membranes; PND, perinatal death; PTB, preterm birth; SAB, spontaneous abortion.